Novartis AG (NVSEF) balance sheet

NVSEFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVS

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30

$146.46+2.56 (+1.78%)

Close on Oct 19, 2026Market cap $279.46BP/E 20.5Yield –

Novartis AG balance sheet

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash & Equivalents	11,435	11,459	13,393	7,517	12,407	9,658	11,112	13,271	8,860	7,007	4,674	13,023
Cash & Short-Term Investments	11,435	11,459	13,393	7,517	12,407	9,658	11,112	13,271	8,860	7,007	4,674	13,023
Receivables	8,937	7,423	7,107	8,066	8,005	8,217	8,301	8,727	8,600	8,202	–	–
Inventory	6,269	5,723	5,913	7,175	6,666	7,131	5,982	6,956	6,867	6,255	–	–
Other Current Assets	514	288	–	–	–	–	–	–	–	–	–	–
Total Current Assets	30,460	29,704	30,481	36,910	45,718	29,673	29,504	35,563	28,208	24,931	–	–
Property, Plant & Equipment	10,782	9,458	9,514	10,764	11,545	12,263	12,069	15,696	16,464	15,641	–	–
Operating Lease Right-of-Use Assets	1,570	1,415	1,410	1,431	1,561	1,676	1,677	1,550	–	–	–	–
Goodwill	25,567	24,756	23,341	29,301	29,595	29,999	26,524	35,294	31,750	30,980	–	–
Intangible Assets	29,411	26,915	26,879	31,644	34,182	36,809	28,787	38,719	29,997	31,340	–	–
Deferred Tax Assets	5,438	4,359	4,309	3,739	3,743	3,933	7,909	8,699	8,229	10,034	–	–
Other Long-Term Assets	5,275	3,505	1,199	1,110	2,210	892	738	895	818	698	–	–
Total Assets	110,949	102,246	99,945	117,453	131,795	127,778	118,370	145,563	133,079	130,124	–	–
Short-Term Debt	682	642	624	863	899	976	719	701	692	836	–	–
Current Portion of Long-Term Debt	794	3,356	2,191	2,241	2,621	2,272	2,002	3,190	359	178	–	–
Current Debt	1,476	3,998	2,815	3,104	3,520	3,248	2,721	3,891	1,051	1,014	–	–
Current Portion of Leases	263	235	230	251	275	286	246	–	–	–	–	–
Current Income Taxes Payable	1,969	1,599	1,893	2,533	2,415	2,458	2,194	2,038	1,723	1,603	–	–
Total Current Liabilities	27,278	28,692	26,390	28,656	30,208	33,059	28,264	29,607	23,403	22,209	–	–
Long-Term Leases	1,657	1,568	1,598	1,538	1,621	1,719	1,703	–	–	–	–	–
Operating Lease Liabilities	1,920	1,803	1,828	1,789	1,896	2,005	1,949	1,740	–	–	–	–
Deferred Tax Liabilities	3,397	2,419	2,248	2,686	3,070	3,141	5,867	7,475	5,168	6,657	–	–
Other Long-Term Liabilities	505	514	804	874	519	409	255	497	577	618	–	–
Total Liabilities	64,400	58,120	53,195	58,030	63,973	71,112	62,819	66,871	58,852	55,233	–	–
Total Debt	1,476	3,998	2,815	3,104	3,520	3,248	2,721	3,891	1,051	1,014	–	–
Common Stock	766	793	825	890	901	913	936	944	969	972	991	1,001
Treasury Stock	-50	-53	-41	-92	-48	-53	-80	-69	-100	-76	-101	-103
Shareholders' Equity	46,130	44,046	46,667	59,342	67,655	56,598	55,474	78,614	74,168	74,832	–	–
Noncontrolling Interest	419	80	83	81	167	68	77	78	59	59	–	–
Total Equity	46,549	44,126	46,750	59,423	67,822	56,666	55,551	78,692	74,227	74,891	77,122	70,844
Total Liabilities & Equity	110,949	102,246	99,945	117,453	131,795	127,778	118,370	145,563	133,079	130,124	–	–
Shares Outstanding(shares)	1,908	1,975	2,044	2,120	2,235	2,257	2,265	2,311	2,318	2,374	2,374	2,399

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 31.0%

Financial strength

Current ratio: 0.86
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 24.0%

Valuation

P/E ratio: 20.5
Price to sales: –
Price to book: 6.73
Dividend yield: –

See a number that looks wrong?